257 related articles for article (PubMed ID: 34250606)
1. Effect of levetiracetam and oxcarbazepine on 4-year fragility fracture risk among prepubertal and pubertal children with epilepsy.
Whitney DG; Caird MS; Hurvitz EA; Rajapakse CS; Fedak Romanowski EM
Epilepsia; 2021 Sep; 62(9):2180-2189. PubMed ID: 34250606
[TBL] [Abstract][Full Text] [Related]
2. The effect of age when initiating anti-seizure medication therapy on fragility fracture risk for children with epilepsy.
Whitney DG; Kalia V; Rajapakse CS; Fedak Romanowski EM; Caird MS; Hurvitz EA; Jepsen KJ
Bone; 2021 Aug; 149():115996. PubMed ID: 33962082
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
4. Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes.
Suo GH; Zheng YQ; Wu YJ; Tang JH
Acta Neurol Belg; 2021 Oct; 121(5):1265-1273. PubMed ID: 33590471
[TBL] [Abstract][Full Text] [Related]
5. Differential antiseizure medication sensitivity of the Affective Reactivity Index: A randomized controlled trial in new-onset pediatric focal epilepsy.
Loring DW; Meador KJ; Shinnar S; Gaillard WD; Wheless JW; Kessler SK; Conry JA; Berl MM; Burns TG; Glauser TA; Kinkead B; Cnaan A
Epilepsy Behav; 2020 Jan; 102():106687. PubMed ID: 31816478
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.
Liu Y; Wang Y; Li X; Wu X
Front Pediatr; 2024; 12():1336744. PubMed ID: 38711491
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study.
Zhao B; Liao S; Zhong X; Luo Y; Hong S; Cheng M; Zhang J; Li T; Jiang L
Front Neurol; 2022; 13():909191. PubMed ID: 35720076
[TBL] [Abstract][Full Text] [Related]
8. Risk for respiratory and cardiovascular disease and mortality after non-trauma fracture and the mediating effects of respiratory and cardiovascular disease on mortality risk among adults with epilepsy.
Whitney DG; Kannikeswaran S; Whibley D
Epilepsy Res; 2020 Oct; 166():106411. PubMed ID: 32679488
[TBL] [Abstract][Full Text] [Related]
9. Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea.
Chung SJ; Ahn KM; Oh JH; Shim JS; Park HW
Epilepsia; 2021 Jan; 62(1):250-257. PubMed ID: 33188522
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Shukla G; Gupta A; Agarwal P; Poornima S
Epilepsy Behav; 2016 Nov; 64(Pt A):216-218. PubMed ID: 27756024
[TBL] [Abstract][Full Text] [Related]
11. The effects of oxcarbazepine, levetiracetam, and lamotrigine on semen quality, sexual function, and sex hormones in male adults with epilepsy.
Wu D; Chen L; Ji F; Si Y; Sun H
Epilepsia; 2018 Jul; 59(7):1344-1350. PubMed ID: 29889310
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis medication is associated with mortality risk reduction among adults with epilepsy: An observational study.
Whitney DG
Bone; 2021 Sep; 150():116003. PubMed ID: 33984552
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of osteoporosis medication on site-specific fracture-risk attenuation among adults with epilepsy.
Whitney DG
Epilepsia; 2020 Nov; 61(11):2583-2592. PubMed ID: 33090479
[TBL] [Abstract][Full Text] [Related]
14. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
[TBL] [Abstract][Full Text] [Related]
15. The mortality burden attributable to nontrauma fracture for privately insured adults with epilepsy.
Whitney DG; Bell S; McNamara NA; Hurvitz EA
Epilepsia; 2020 Apr; 61(4):714-724. PubMed ID: 32108937
[TBL] [Abstract][Full Text] [Related]
16. Efficacy comparison of oxcarbazepine and levetiracetam monotherapy among patients with newly diagnosed focal epilepsy in China: A multicenter, open-label, randomized study.
Zhu H; Deng X; Feng L; Lian Y; Han X; Guo Z; Gou Y; Du Y; Xie L; Yao D; Liu Y; Wu Q; Lan S; Liu K; Zhan P; Wang X; Dang J; Hou Y; Chen K; Zhu Y; Shi Y; Yu Y; Xiao B; Zhu S; Meng H
CNS Neurosci Ther; 2022 Jul; 28(7):1072-1080. PubMed ID: 35429132
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders.
Dreier JW; Bjørk MH; Alvestad S; Gissler M; Igland J; Leinonen MK; Sun Y; Zoega H; Cohen JM; Furu K; Tomson T; Christensen J
JAMA Neurol; 2023 Jun; 80(6):568-577. PubMed ID: 37067807
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta-analysis.
Kharel S; Ojha R; Khanal S
Brain Behav; 2022 Nov; 12(11):e2779. PubMed ID: 36184821
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of persistence and healthcare utilization in patients treated with anti-seizure medications as add-on therapy: A nationwide cohort study in South Korea.
Lee JW; Kim JA; Kim MY; Lee SK
Epilepsy Behav; 2022 Jan; 126():108459. PubMed ID: 34902660
[TBL] [Abstract][Full Text] [Related]
20. Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy.
Hersi H; Raitanen J; Saarinen JT; Peltola J
Epilepsia Open; 2023 Sep; 8(3):811-819. PubMed ID: 37010264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
